Ушбу иш иқтибос қилган ишлар

154 та иш

Иш: Non-Coding RNAs as key regulators of interferon signaling in cancer immunotherapy: mechanistic insights and clinical prospects

1. CircRNA_100920 enhanced oncolytic adenovirus therapy in colon cancer by suppressing IFN-γ expression

   Shaofeng Yuan, Xiangdong Kong, Wei Yu +3

   Мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816532

2. MiR-139 Induces an Interferon-β Response in Prostate Cancer Cells by Binding to RIG-1

   Robert K. Nam, Tania Benatar, Yutaka Amemiya +1

   Мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816537

3. Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis

   Zhimin Deng, Fangfang Dai, Quan Zhou +1

   Мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816539

4. Double-edged effects of interferons on the regulation of cancer-immunity cycle

   Xiao Zhang, Song Wang, Yuanyuan Zhu +5

   Шарҳ мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816540

5. DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes

   Yui Hatanaka, Takeshi Niinuma, Hiroshi Kitajima +15

   Мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816542

6. Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN/STAT1 signaling pathway

   Yongcan Xu, Jun Lu, Neng Lou +4

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816545

7. Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA

   Ying Zhang, Meiying Luo, Xiaohong Cui +2

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816546

8. Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling

   Siyu Liu, Xiyi Chen, Ke Huang +9

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816551

9. circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment

   Roberta Piras, Emily Ko, Connor Barrett +13

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816552

10. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1–TINCR-USP20-PD-L1 axis

    Qin Wang, Guozheng Li, Xin Ma +10

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816557

11. A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer

    Nan Ding, A‐Bin You, Hu Yang +4

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816558

12. CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity

    Lulu Yu, Qi Xiao, Bing Yu +3

    Шарҳ мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816559

13. Exploring the regulatory role of lncRNA in cancer immunity

    Danting Zhan, Hong-chun Xian

    Шарҳ мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816561

14. Gold nanoparticles attenuate the interferon-γ induced SOCS1 expression and activation of NF-κB p65/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells

    Aisha Farhana, Abdullah Alsrhani, Naila Rasheed +1

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816562

15. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway

    Lin Du, Baojun Wang, Mengtong Wu +8

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816565

16. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways

    Arefeh Zabeti Touchaei, Sogand Vahidi

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816568

17. Engineered nanoparticles promote cardiac tropism of AAV vectors

    Lauren Switala, Lin Di, Huiyun Gao +5

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816570

18. NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis

    Zimu Wang, Jing Luo, Hairong Huang +12

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816571

19. lncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin

    Xiaoyan Yin, Haizhong Zhang, Jingmiao Wang +4

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816572

20. ADAR1-regulated miR-142-3p/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma

    Haoyuan Xu, Wanpeng Li, Kai Xue +9

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816573

21. Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response

    Kim Denise Fischer, Shashank Tiwari, Beatrice Thier +4

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816574

22. HOXA11-As Promotes Lymph Node Metastasis Through Regulation of IFNL and HMGB Family Genes in Pancreatic Cancer

    Hayato Nishiyama, Takeshi Niinuma, Hiroshi Kitajima +9

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816576

23. The AhR regulates IFN-induced immune checkpoints in lung cancer cells through HNRNPH1, an RNA-binding protein, and INCR1, a novel long non-coding RNA

    Brian Lara, Megan Snyder, Jocelyn Fimbres +5

    Мақола20252 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816578

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816462

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816466